Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug
Clinical trial NCT04470453 · TERMINATED
Trial details
- NCT number
- NCT04470453
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2024-04-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.